Evidence map›Paper›PMID 35794528›Full record

ArticleBMC bioinformatics2022

Exploring deep learning methods for recognizing rare diseases and their clinical manifestations from texts.

Isabel Segura-Bedmar, David Camino-Perdones, Sara Guerrero-Aspizua

Abstract read
In one paragraph

Article in BMC bioinformatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Synonym Augmentation for Rare Disease Identification in Unstructured Data.medRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Large Language Models Struggle in Token-Level Clinical Named Entity Recognition.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Isabel Segura-BedmarHuman Language and Accesibility Technologies, Computer Science Department, Universidad Carlos III de Madrid, Avenidad de la Universidad, 30, Leganés, 28911, Madrid, Spain. isegura@inf.uc3m.es.
David Camino-PerdonesHuman Language and Accesibility Technologies, Computer Science Department, Universidad Carlos III de Madrid, Avenidad de la Universidad, 30, Leganés, 28911, Madrid, Spain.
Sara Guerrero-AspizuaTissue Engineering and Regenerative Medicine group, Department of Bioengineering, Universidad Carlos III de Madrid, Avenidad de la Universidad, 30, Leganés, 28911, Madrid, Spain.

Funding

Comunidad de Madrid NLP4Rare-CM-UC3MMinisterio de Ciencia e Innovación PID2020-116527RB-I00
6 · The paper itself

Abstract

BACKGROUND AND

objectiveAlthough rare diseases are characterized by low prevalence, approximately 400 million people are affected by a rare disease. The early and accurate diagnosis of these conditions is a major challenge for general practitioners, who do not have enough knowledge to identify them. In addition to this, rare diseases usually show a wide variety of manifestations, which might make the diagnosis even more difficult. A delayed diagnosis can negatively affect the patient's life. Therefore, there is an urgent need to increase the scientific and medical knowledge about rare diseases. Natural Language Processing (NLP) and Deep Learning can help to extract relevant information about rare diseases to facilitate their diagnosis and treatments.

methodsThe paper explores several deep learning techniques such as Bidirectional Long Short Term Memory (BiLSTM) networks or deep contextualized word representations based on Bidirectional Encoder Representations from Transformers (BERT) to recognize rare diseases and their clinical manifestations (signs and symptoms).

resultsBioBERT, a domain-specific language representation based on BERT and trained on biomedical corpora, obtains the best results with an F1 of 85.2% for rare diseases. Since many signs are usually described by complex noun phrases that involve the use of use of overlapped, nested and discontinuous entities, the model provides lower results with an F1 of 57.2%.

conclusionsWhile our results are promising, there is still much room for improvement, especially with respect to the identification of clinical manifestations (signs and symptoms).

Indexed as

Deep LearningRare DiseasesHumansLanguageNatural Language ProcessingDeep learningNamed entity recognitionRare diseases

Identifiers

PMID35794528
PMCPMC9258216

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.